1-3 of 3
George Mellgard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Multi-Institution Phase 2, Single-Arm, Non-Inferiority Study of Limited-Duration Teclistamab for Relapsed and Refractory Multiple Myeloma (LimiTec)

Beatrice Razzo, Sarah Girgis, Leonard Finnaca, Samantha Le, Sara Whittington, George Mellgard, Connor B Grady, Zachary Wolfe, Adam F. Binder, Rajshekhar Chakraborty, Christopher Strouse, Hira Shaikh, Shivani Kapur, Sandra Susanibar-Adaniya, Adam Waxman, Dan T. Vogl, Adam D. Cohen, Edward A. Stadtmauer, Wei-Ting Hwang, Alfred L. Garfall
Journal: Blood
Blood (2024) 144 (Supplement 1): 3381.1.
https://doi.org/10.1182/blood-2024-199411
Published: 2024
Journal Articles

Development of a Risk Prediction Model for 6-Month Early Mortality in Patients with Systemic Light Chain Amyloidosis Treated with Daratumumab-Based Frontline Therapy

George Mellgard, Abdul-hamid Bazarbachi, Saurabh Zanwar, Ute Hegenbart, Geethika Bodanapu, Divaya Bhutani, Guizhen Chen, Anita D'Souza, Angela Dispenzieri, Morie A. Gertz, Shaji Kumar, Suzanne Lentzsch, Paolo Milani, Eli Muchtar, Giovanni O. Palladini, Anannya Patwari, Vaishali Sanchorawala, Shikun Wang, Stefan O. Schönland, Rajshekhar Chakraborty, Andrew J. Cowan
Journal: Blood
Blood (2024) 144 (Supplement 1): 287.
https://doi.org/10.1182/blood-2024-202589
Published: 2024
Journal Articles

Risk Stratification Models Overestimate Progression Risk in Contemporary Patients with Smoldering Multiple Myeloma (SMM)

George Mellgard, Molly Gilligan, Edward R Scheffer Cliff, Divaya Bhutani, Ghulam Rehman Mohyuddin, Andrew Eisenberger, Suzanne Lentzsch, Rajshekhar Chakraborty
Journal: Blood
Blood (2023) 142 (Supplement 1): 4768.
https://doi.org/10.1182/blood-2023-174908
Published: 2023